ID: ALA4573866

Max Phase: Preclinical

Molecular Formula: C15H12N4O2

Molecular Weight: 280.29

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1ccc(-c2cn(-c3ccc(C(=O)O)cc3)nn2)cc1

Standard InChI:  InChI=1S/C15H12N4O2/c16-12-5-1-10(2-6-12)14-9-19(18-17-14)13-7-3-11(4-8-13)15(20)21/h1-9H,16H2,(H,20,21)

Standard InChI Key:  GOWLCEQWOYBWGX-UHFFFAOYSA-N

Associated Targets(non-human)

ORF 73 309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 280.29Molecular Weight (Monoisotopic): 280.0960AlogP: 2.21#Rotatable Bonds: 3
Polar Surface Area: 94.03Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.53CX Basic pKa: 3.07CX LogP: 2.38CX LogD: -0.26
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.72Np Likeness Score: -1.39

References

1. Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M..  (2019)  Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.,  62  (8): [PMID:30888817] [10.1021/acs.jmedchem.8b01827]

Source